Genomic abnormalities of waldenström macroglobulinemia and related low-grade B-cell lymphomas

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Waldenström macroglobulinemia (WM) is a lymphoproliferative disease characterized by a heterogeneous lymphoplasmacytic bone marrow infiltrate and monoclonal immunoglobulin M production. WM shows similarities in presentations with related B-cell malignancies, sometimes making it difficult to distinguish them. To better characterize the genetic basis of WM, we performed a comparative genomic analysis with the related entities, lymphoplasmacytic lymphomas without monoclonal immunoglobulin M protein, marginal zone lymphomas, chronic lymphocytic leukemia, and monoclonal gammopathy of undetermined significance. Overall, WM shows a very stable karyotype and shares most of the chromosomal abnormalities with most of the indolent B-cell malignancies. Trisomy 4 is unique to WM; however, no candidate genes have been identified in the chromosome. Abnormalities that affect myeloid differentiation primary response 88 (MYD88) - interleukin-1 receptor-associated kinase 4 (IRAK4) and nuclear factor kappa B (NF-κB) signaling pathways were found in a significant proportion of WM cases, which suggest their relevance in the pathogenesis of the disease and opening new avenues that may be a guide to design novel therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)198-201
Number of pages4
JournalClinical Lymphoma, Myeloma and Leukemia
Issue number2
StatePublished - Apr 2013


  • Array-based comparative genomic hybridization
  • Low-grade B-cell lymphomas
  • Nuclear factor kappa B signaling pathway
  • Waldenström macroglobulinemia

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Genomic abnormalities of waldenström macroglobulinemia and related low-grade B-cell lymphomas'. Together they form a unique fingerprint.

Cite this